Financhill
Back

Kazia Therapeutics Quote, Financials, Valuation and Earnings

Kazia Therapeutics Price Quote

$4.60
+0.03 (+-12.71%)
(Updated: November 16, 2024 at 5:26 AM ET)

Kazia Therapeutics Key Stats

Sell
47
Kazia Therapeutics (KZIA) is a Sell

Day range:
$4.30 - $5.41
52-week range:
$1.87 - $15.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
98.2K
Avg. volume:
169.1K
1-year change:
-40.88%
Market cap:
$15.2M
Revenue:
$0
EPS:
$-0.37

How Much Does Kazia Therapeutics Make?

Data Unavailable

Is Kazia Therapeutics Growing As A Company?

  • What Is Kazia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.96%
  • What Is Kazia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Kazia Therapeutics Stock Price Performance

What Is Kazia Therapeutics 52-Week High & Low?

Kazia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kazia Therapeutics?

Is Kazia Therapeutics Cash Flow Positive?

  • What Is KZIA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.4M
  • What Is Kazia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.9M
  • What Is Kazia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Kazia Therapeutics Return On Invested Capital

Data Unavailable

Kazia Therapeutics Earnings Date & Stock Price

Kazia Therapeutics Competitors

Kazia Therapeutics Dividend Yield

Kazia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -95.91% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.98
Upside from Last Price: 337.26%

Major Shareholders

  • How many KZIA shares are owned by institutional investors?
    5.1M KZIA shares are owned by institutional investors
  • How many KZIA shares are owned by insiders?
    19.8K KZIA shares are owned by insiders